Home

Prognosis

Read time: 3 min

Congress highlights

Fine-tuning psychiatric diagnosis to guide treatment and prognosis

Syndromal psychiatric diagnoses are based on guidance provided by the International Classification...

Read time: 5 min

Congress highlights

Ultra High Risk – fact or fiction?

An EPA 2019 debate presented the data supporting the cases both for and against abandonment of...

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Read the full article here.

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Alzheimer's Disease

Read time: 3 min

Congress highlights

Early palliative care in progressive neurological diseases

Neurologists are often dealing with chronic diseases that progress in severity. Palliative care...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Study motivated by apathy

Conversion from mild cognitive impairment to Alzheimer’s disease dementia is not related to...

Parkinson's Disease

Read time: 2 min

Congress highlights

Search for risk signature moves into crucial second phase

Parkinson Progression Marker Initiative 2.0, a Michael J Fox Foundation initiative, is ready to...

Alcohol Dependence

Read time: 2 min

Congress highlights

What is the link between post-traumatic stress disorder and substance use disorder?

Why does extreme emotional trauma cause post-traumatic stress disorder (PTSD) in some people, but...

Read time: 3 min

Congress highlights

How does the brain change with bipolar disorder?

Mania in adolescence and young adulthood is highly predictive of bipolar disorder type 1 (BPD1),...

Read time: 3 min

Congress highlights

Core components of the Coordinated Specialty Care model for first-episode psychosis

The Coordinated Specialty Care (CSC) model for first-episode psychosis (FEP) is an evidence-based...

Read time: 3 min

Congress highlights

The new technologies transforming psychiatric practice and patient outcomes

Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information...

Parkinson's Disease

Read time: 3 min

Congress highlights

The challenge of recognizing and managing complications of advanced Parkinson’s disease

The recurrence of classical motor symptoms of Parkinson’s disease (PD) signifies the end of...

Parkinson's Disease

Read time: 3 min

Congress highlights

EAN 2019: Research highlights in Parkinson’s disease

During a presentation on “highlights in movement disorders” at the EAN Congress, key...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country